Onofrio Laselva

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 12

Top Venues

Journal of personalized medicine

Cells

Expert opinion on drug discovery

EMBO molecular medicine

UNIVERSITA' DEGLI STUDI DI FOGGIA

Università degli Studi di Bari Aldo Moro (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UNIVERSITA' DEGLI STUDI DI FOGGIA Jun 15 2020 - Jun 15 2023

Italy

Ricercatori a tempo determinato :: Dipartimento di Scienze Mediche e Chirurgiche

Education History

Università degli Studi di Bari Aldo Moro Jan 01 2014

Italy

PHD

Università degli Studi di Bari Aldo Moro Jan 02 2011 - Mar 20 2013

Italy

MSC

Università degli Studi di Bari Aldo Moro Oct 01 2007 - Oct 07 2010

Italy

BSC

Publications

Onofrio Laselva, Massimo Conese
Elexacaftor/Tezacaftor/Ivacaftor Accelerates Wound Repair in Cystic Fibrosis Airway Epithelium. Journal of personalized medicine 12 (10) (2022)
Sang Hyun Lim, Jamie Snider, Liron Birimberg-Schwartz, Wan Ip, Joana C Serralha, Hugo M Botelho, Miquéias Lopes-Pacheco, Madalena C Pinto, Mohamed Taha Moutaoufik, Mara Zilocchi, Onofrio Laselva, Mohsen Esmaeili, Max Kotlyar, Anna Lyakisheva, Priscilla Tang, Lucía López Vázquez, Indira Akula, Farzaneh Aboualizadeh, Victoria Wong, Ingrid Grozavu, Teuta Opačak-Bernardi, Zhong Yao, Meg Mendoza, Mohan Babu, Igor Jurisica, Tanja Gonska, Christine E Bear, Margarida D Amaral, Igor Stagljar
CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system. Molecular systems biology 18 (2) (2022)
Vito Terlizzi, Claudia Centrone, Beatrice Ferrari, Chiara Castellani, Tarini N A Gunawardena, Giovanni Taccetti, Onofrio Laselva
Modulator Therapy in Cystic Fibrosis Patients with cis Variants in F508del Complex Allele: A Short-Term Observational Case Series. Journal of personalized medicine 12 (9) (2022)
Iris A L Silva, Onofrio Laselva, Miquéias Lopes-Pacheco
Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis. Journal of personalized medicine 12 (8) (2022)
Onofrio Laselva, Caterina Allegretta, Sante Di Gioia, Carlo Avolio, Massimo Conese
Anti-Inflammatory and Anti-Oxidant Effect of Dimethyl Fumarate in Cystic Fibrosis Bronchial Epithelial Cells. Cells 10 (8) (2021)
Onofrio Laselva, Claire Bartlett, Tarini N A Gunawardena, Hong Ouyang, Paul D W Eckford, Theo J Moraes, Christine E Bear, Tanja Gonska
Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator. The European respiratory journal 57 (6) (2021)
Onofrio Laselva, Maria C Ardelean, Christine E Bear
Phenotyping Rare CFTR Mutations Reveal Functional Expression Defects Restored by TRIKAFTATM. Journal of personalized medicine 11 (4) (2021)
Sunny Xia, Zoltán Bozóky, Michelle Di Paola, Onofrio Laselva, Saumel Ahmadi, Jia Xin Jiang, Amy L Pitstick, Chong Jiang, Daniela Rotin, Christopher N Mayhew, Nicola L Jones, Christine E Bear
High-Throughput Functional Analysis of CFTR and Other Apically Localized Proteins in iPSC-Derived Human Intestinal Organoids. Cells 10 (12) (2021)
Lorenzo Guerra, Maria Favia, Sante Di Gioia, Onofrio Laselva, Arianna Bisogno, Valeria Casavola, Carla Colombo, Massimo Conese
The preclinical discovery and development of the combination of ivacaftor + tezacaftor used to treat cystic fibrosis. Expert opinion on drug discovery 15 (8) (2020)
Onofrio Laselva, Tracy A Stone, Christine E Bear, Charles M Deber
Anti-Infectives Restore ORKAMBI® Rescue of F508del-CFTR Function in Human Bronchial Epithelial Cells Infected with Clinical Strains of P. aeruginosa. Biomolecules 10 (2) (2020)
Onofrio Laselva, Jacqueline McCormack, Claire Bartlett, Wan Ip, Tarini N A Gunawardena, Hong Ouyang, Paul D W Eckford, Tanja Gonska, Theo J Moraes, Christine E Bear
Preclinical Studies of a Rare CF-Causing Mutation in the Second Nucleotide Binding Domain (c.3700A>G) Show Robust Functional Rescue in Primary Nasal Cultures by Novel CFTR Modulators. Journal of personalized medicine 10 (4) (2020)
Steven V Molinski, Saumel Ahmadi, Wan Ip, Hong Ouyang, Adriana Villella, John P Miller, Po-Shun Lee, Kethika Kulleperuma, Kai Du, Michelle Di Paola, Paul Dw Eckford, Onofrio Laselva, Ling Jun Huan, Leigh Wellhauser, Ellen Li, Peter N Ray, Régis Pomès, Theo J Moraes, Tanja Gonska, Felix A Ratjen, Christine E Bear
Orkambi® and amplifier co-therapy improves function from a rare CFTR mutation in gene-edited cells and patient tissue. EMBO molecular medicine 9 (9) (2018)

Onofrio Laselva.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Onofrio Laselva